Particle.news
Download on the App Store
36 ARTICLES
·
2h ago

ED Raids Seven Chennai Sites Tied to Coldrif Maker as Tamil Nadu Cancels Licence and Shuts Plant

The searches follow child fatalities linked to a batch that tested positive for 48.6% diethylene glycol.

Saddam Mansuri, the father of two, shows bottles of Coldrif, linked to the deaths of several children and a Relife cough syrup, which is not linked to any deaths, but Indian authorities have asked people to avoid it, which he had been giving his one-year-old child, in Parasia, Madhya Pradesh, India, October 10, 2025. REUTERS/Priyanshu Singh
Image
Image
Image

Overview

  • Enforcement Directorate teams executed PMLA searches at seven Chennai locations linked to Sresan/Sreesan Pharma and residences of senior Tamil Nadu Drug Control officials, including a former joint director.
  • Tamil Nadu’s health department revoked Sresan’s manufacturing licence and ordered the facility closed after inspectors recorded more than 300 major GMP and GLP violations.
  • Owner G. Ranganathan was arrested last week by a Madhya Pradesh SIT and is in police custody on charges including culpable homicide and drug adulteration.
  • Authorities identified the implicated Coldrif batch as SR-13 (manufactured May 2025, expiry April 2027), with DEG levels reported at roughly 48.6%, and the syrup has been linked to at least 20 child deaths in Madhya Pradesh and Rajasthan.
  • State and central regulators have ordered wider inspections and stricter testing, while the ED probe seeks to trace proceeds of crime and potential regulatory collusion.